Arotech Corporation Reports Results For The Third Quarter And First Nine Months, 2014
Revenues, operating profit, EBITDA and net profit for 2014 all continue up; 2014 EBITDA guidance again increased
ANN ARBOR, Mich., Nov. 10, 2014 /PRNewswire/ -- Arotech Corporation (Nasdaq GM: ARTX), a provider of quality defense and security products for the military, law enforcement and security markets, today reported results for the quarter and nine months ended September 30, 2014.
Third Quarter Results
Revenues for the third quarter reached $24.8 million, compared to $23.2 million for the corresponding period in 2013, an increase of 6.9%.
Gross profit for the quarter was $8.0 million, or 32.3% of revenues, compared to $6.4 million, or 27.5% of revenues, for the corresponding period last year, a 4.8 point improvement in the gross margin percentage.
Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (adjusted EBITDA) for the quarter was $2.6 million, compared to $2.2 million for the corresponding period in 2013. Arotech believes that information concerning adjusted EBITDA enhances overall understanding of its current financial performance. Arotech computes adjusted EBITDA, which is a non-GAAP financial measure, as reflected in the table below.
The Company reported an operating profit for the third quarter of 2014 of $1.2 million, compared to an operating profit of $1.4 million for the corresponding period in 2013. Operating expenses in the quarter grew to $6.8 million versus $5.0 million in the corresponding quarter in 2013. A large portion of the increase was due to the consolidation of the operations of UEC, which was acquired at the start of the second quarter, as well as an increase in R&D investment related to development of the Company's iron flow battery technology.
The Company's net income from continuing operations for the third quarter was $379,000, or $0.02 per diluted share, compared to net income of $861,000, or $0.05 per share, for the corresponding period last year.
First Nine Months Results
Revenues for the first nine months of 2014 reached $75.0 million, compared to $67.6 million for the corresponding period last year, an increase of 10.9%.
Gross profit for the first nine months of 2014 was $25.3 million, or 33.8% of revenues, compared to $18.0 million, or 26.5% of revenues, for the corresponding period last year, a 7.3 point improvement in the gross margin percentage.
Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (adjusted EBITDA) for the first nine months of 2014 was $8.9 million, compared to $6.2 million for the corresponding period last year. Arotech believes that information concerning adjusted EBITDA enhances overall understanding of its current financial performance. Arotech computes adjusted EBITDA, which is a non-GAAP financial measure, as reflected in the table below.
The Company reported an operating profit for the first nine months of 2014 of $4.8 million, compared to an operating profit of $3.8 million for the corresponding period in 2013.
The Company's net income from continuing operations for the first nine months of 2014 was $3.2 million, or $0.15 per share, versus a net income of $2.8 million, or $0.17 per diluted share, for the corresponding period last year.
Backlog
Backlog of orders totaled approximately $74.1 million as of September 30, 2014, as compared to $74.4 million at September 30, 2013 and $74.1 million as of June 30, 2014.
Balance Sheet Metrics
As of September 30, 2014, the Company had $10.8 million in cash and $242,000 in restricted collateral deposits, as compared to December 31, 2013, when the Company had $5.8 million in cash and $498,000 in restricted collateral deposits.
The Company ended the third quarter with $2.8 million in short-term bank debt under its credit facility and $22.7 million in long-term loans outstanding, which included $4.3 million in current debt and $18.4 million in long term debt. This is in comparison to December 31, 2013 when the Company had no short-term bank debt under its credit facility and $1.9 million in long-term loans outstanding, which included $95,000 in current debt and $1.8 million in long term debt. The increase in bank loans was due to the long term debt associated with the purchase of UEC.
The Company also had $7.7 million in available, unused bank lines of credit with its main bank as of September 30, 2014, under a $15.0 million credit facility under its FAAC subsidiary, which was secured by the Company's assets and the assets of the Company's other subsidiaries and guaranteed by the Company.
The Company had trade receivables of $14.9 million as of September 30, 2014, compared to $12.4 million as of December 31, 2013. The Company had a current ratio (current assets/current liabilities) of 2.1, compared with the December 31, 2013 current ratio of 2.1.
Management Comment
"We are pleased to present another set of excellent quarterly results," commented Arotech's President and CEO, Steven Esses. "Gross margins continue to significantly surpass expectations, and as a result, despite the slippage of some revenues into future quarters, our profit and EBITDA have continued to rise. As a result, we are raising EBITDA guidance for 2014," concluded Mr. Esses.
Revised Guidance
For the full year 2014, Arotech's management continues to expect that full year revenues will exceed $105 million. Management increases its guidance for 2014 adjusted EBITDA , expecting in the range of between $9.2 million and $9.5 million, an increase from the formerly expected range of between $7.8 million and $8.3 million. The financial guidance provided is as of today and Arotech undertakes no obligation to update its estimates in the future.
Conference Call
The Company will host a conference call tomorrow, Tuesday, November 11, 2014 at 9:00 a.m. EST. Those wishing to access the conference call should dial 1-888-407-2553 (U.S.) or +1-347-293-1926 (international) a few minutes before the 9:00 a.m. EST start time. For those unable to participate, the teleconference will be available for replay on Arotech's website at http://www.arotech.com/ beginning 24 hours after the call.
About Arotech Corporation
Arotech Corporation is a leading provider of quality defense and security products for the military, law enforcement and homeland security markets. Arotech provides multimedia interactive simulators/trainers and advanced zinc-air and lithium batteries and chargers. Arotech operates through two major business divisions: Training and Simulation, and Batteries and Power Systems.
Arotech is incorporated in Delaware, with corporate offices in Ann Arbor, Michigan and research, development and production subsidiaries in Alabama, Michigan, South Carolina and Israel.
Investor Relations Contacts: Ehud Helft & Kenny Green GK Investor Relations Tel: 1 646 201 9246 |
Except for the historical information herein, the matters discussed in this news release include forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, readers are cautioned not to place undue reliance on these forward-looking statements, as they are subject to various risks and uncertainties that may cause actual results to vary materially. These risks and uncertainties include, but are not limited to, risks relating to: product and technology development; the uncertainty of the market for Arotech's products; changing economic conditions; delay, cancellation or non-renewal, in whole or in part, of contracts or of purchase orders (including as a result of budgetary cuts resulting from automatic sequestration under the Budget Control Act of 2011); and other risk factors detailed in Arotech's most recent Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2013 and in Exhibit 99.3 to Arotech's Current Report on 8-K, filed on April 1, 2014, and other filings with the Securities and Exchange Commission. Arotech assumes no obligation to update the information in this release. Reference to the Company's website above does not constitute incorporation of any of the information thereon into this press release.
TABLES TO FOLLOW
BALANCE SHEET SUMMARY ANALYSIS (UNAUDITED) (U.S. Dollars)
|
|||||||
September 30, |
December 31, |
||||||
ASSETS |
|||||||
CURRENT ASSETS: |
|||||||
Cash and cash equivalents |
$ |
11,044,256 |
$ |
6,319,820 |
|||
Trade receivables |
14,911,644 |
12,362,871 |
|||||
Unbilled receivables |
19,036,156 |
8,463,920 |
|||||
Other accounts receivable and prepaid |
1,544,692 |
1,379,621 |
|||||
Inventories |
10,711,913 |
10,074,766 |
|||||
Total current assets |
57,248,661 |
38,600,998 |
|||||
LONG TERM ASSETS: |
|||||||
Property and equipment, net |
6,114,138 |
4,926,949 |
|||||
Other long term assets |
4,984,775 |
5,042,790 |
|||||
Intangible assets, net |
12,396,306 |
1,059,151 |
|||||
Goodwill |
45,730,986 |
31,024,754 |
|||||
Total long term assets |
69,226,205 |
42,053,644 |
|||||
Total assets |
$ |
126,474,866 |
$ |
80,654,642 |
|||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||||
CURRENT LIABILITIES: |
|||||||
Trade payables |
$ |
4,803,969 |
$ |
5,107,208 |
|||
Other accounts payable and accrued expenses |
8,532,938 |
6,012,041 |
|||||
Current portion of long term debt |
4,340,729 |
95,382 |
|||||
Short term bank credit |
2,782,213 |
– |
|||||
Deferred revenues |
6,300,162 |
7,020,079 |
|||||
Total current liabilities |
26,760,011 |
18,234,710 |
|||||
LONG TERM LIABILITIES: |
|||||||
Long term portion of debt |
18,357,684 |
1,830,348 |
|||||
Other long-term liabilities |
15,546,271 |
12,612,608 |
|||||
Total long-term liabilities |
33,903,955 |
14,442,956 |
|||||
Total liabilities |
60,663,966 |
32,677,666 |
|||||
STOCKHOLDERS' EQUITY: |
|||||||
Total stockholders' equity (net) |
65,810,900 |
47,976,976 |
|||||
Total liabilities and stockholders' equity |
$ |
126,474,866 |
$ |
80,654,642 |
|||
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) |
|||||||
Nine months ended September 30, |
Three months ended September 30, |
||||||
2014 |
2013 |
2014 |
2013 |
||||
Revenues |
$ 74,995,339 |
$ 67,637,517 |
$ 24,783,353 |
$ 23,187,544 |
|||
Cost of revenues |
49,682,017 |
49,681,174 |
16,775,556 |
16,816,012 |
|||
Research and development expenses |
2,857,144 |
1,935,958 |
925,186 |
807,788 |
|||
Selling and marketing expenses |
4,180,519 |
3,549,483 |
1,202,966 |
1,229,225 |
|||
General and administrative expenses |
11,606,038 |
7,539,580 |
3,799,772 |
2,685,522 |
|||
Amortization of intangibles |
1,828,635 |
821,097 |
867,452 |
270,985 |
|||
Total operating costs and expenses |
70,154,353 |
63,827,292 |
23,570,932 |
21,809,532 |
|||
Operating income |
4,840,986 |
3,810,225 |
1,212,421 |
1,378,012 |
|||
Other income |
288,252 |
261,222 |
58,831 |
(7,460) |
|||
Financial expenses, net |
(1,098,755) |
(475,448) |
(416,107) |
(172,569) |
|||
Total other expense |
(810,503) |
(214,226) |
(357,276) |
(180,029) |
|||
Income from continuing operations before income tax expense |
4,030,483 |
3,595,999 |
855,145 |
1,197,983 |
|||
Income tax expense |
855,178 |
765,962 |
476,617 |
337,060 |
|||
Income from continuing operations |
3,175,305 |
2,830,037 |
378,528 |
860,923 |
|||
Loss from discontinued operations, net of income tax |
- |
(87,278) |
- |
652 |
|||
Net income |
3,175,305 |
2,742,759 |
378,528 |
861,575 |
|||
Other comprehensive income, net of income tax |
|||||||
Foreign currency translation adjustment |
(648,740) |
472,767 |
(749,849) |
58,247 |
|||
Comprehensive income |
$ 2,526,565 |
$ 3,215,526 |
$ (371,321) |
$ 919,822 |
|||
Basic net income per share – continuing operations |
$ 0.15 |
$ 0.18 |
$ 0.02 |
$ 0.05 |
|||
Basic net loss per share – discontinued operations |
$ - |
$ (0.01) |
$ - |
$ - |
|||
Basic net income per share |
$ 0.15 |
$ 0.17 |
$ 0.02 |
$ 0.05 |
|||
Diluted net income per share – continuing operations |
$ 0.15 |
$ 0.18 |
$ 0.02 |
$ 0.05 |
|||
Diluted net loss per share – discontinued operations |
$ - |
$ (0.01) |
$ - |
$ - |
|||
Diluted net income per share |
$ 0.15 |
$ 0.17 |
$ 0.02 |
$ 0.05 |
|||
Weighted average number of shares used in computing basic net income/loss per share |
20,998,023 |
15,521,974 |
23,137,808 |
15,951,602 |
|||
Weighted average number of shares used in computing diluted net income/loss per share |
21,600,763 |
16,124,714 |
23,740,548 |
16,554,342 |
Reconciliation of Non-GAAP Financial Measure – Continuing Operations
To supplement Arotech's consolidated financial statements presented in accordance with U.S. GAAP, Arotech uses a non-GAAP measure, Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA). This non-GAAP measure is provided to enhance overall understanding of Arotech's current financial performance. Reconciliation of Adjusted EBITDA to the nearest GAAP measure follows:
Nine months ended September 30, |
Three months ended September 30, |
|||||||
2014 |
2013 |
2014 |
2013 |
|||||
Net Income continuing (GAAP measure) |
$ 3,175,305 |
$ 2,830,037 |
$ 378,528 |
$ 860,923 |
||||
Add back: |
||||||||
Financial (income) expense – including interest |
810,503 |
475,448 |
357,276 |
172,569 |
||||
Income tax expenses (benefit) |
855,178 |
765,962 |
476,617 |
337,060 |
||||
Depreciation and amortization expense |
2,945,234 |
1,688,105 |
1,289,709 |
555,087 |
||||
Other adjustments* |
1,160,644 |
392,913 |
143,930 |
226,381 |
||||
Total adjusted EBITDA |
$ 8,946,864 |
$ 6,152,465 |
$ 2,646,060 |
$ 2,152,020 |
||||
* Includes stock compensation expense, one-time transaction expenses and other non-cash expenses.
SOURCE Arotech Corporation
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article